COVI-001 already has shown great potential to become the standard of care for those with late-stage COVID-19, thereby alleviating suffering and saving lives around the world.

CovInnovations™ has assembled a top-tier team of professionals who are capable of bringing this innovative product to market. We already have applied for FDA approval and are making necessary contacts for large-scale production and distribution.

We welcome inquiry from those interested in being a part of this revolutionary product, as well as other technologies currently under development. Please email investor.relations@covinnovations.com to register.